Healthcare ❯ Pharmaceuticals

Drug Companies

Regulatory Compliance Market Performance AstraZeneca Pfizer GSK Regulatory Issues Investment Opportunities Pricing Strategies Market Trends Eli Lilly Sanofi Oncology AbbVie Revenue Growth Opioid Crisis Dividend Policies Major Pharmaceutical Companies Market Competition Market Value

Reuters Says There Were No AstraZeneca‑Bristol Myers Merger Talks

The denial calmed market moves, highlighting steep antitrust and patent hurdles for any proposed megadeal.

AbbVie Faces Pre-Earnings Test This Month

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

Eli Lilly Tightens GLP-1 Grip, Guides Up to $83 Billion for 2026

HSBC Upgrades AbbVie to Buy, Lifts Target to $265 as Skyrizi and Rinvoq Drive Growth

Bristol Myers and J&J Cast as Dividend Plays as Bayer’s FXIa Win Refocuses Pipeline Interest

Yahoo Finance Flags One Pharma Dividend Buy as Sector Slumps